Senior Fellow, Health Law Institute
President & CEO, Whitelaw Compliance Group, LLC
Dr. Seth Whitelaw has more than 25 years of industry experience in the life sciences and healthcare sectors, as an attorney, compliance officer, and consultant, Dr. Whitelaw has formed his own consulting firm, Whitelaw Compliance Group, dedicated to helping small to medium-sized FDA-regulated companies grow and achieve sustainable compliance and integrity.
His career has focused on food and drug law, and corporate governance, as well as designing and running corporate compliance programs within medical devices, pharmaceutical sales, and marketing and pharmaceutical R&D. He is a licensed food and drug attorney, with a doctorate in Health Law.
In his various roles, Dr. Whitelaw has worked for the FDA’s Office of Chief Counsel, participated in Corporate Integrity Agreement negotiations, and implemented four (4) successful corporate compliance programs from a “blank sheet of paper” in the fields of medical devices, pharmaceutical sales and marketing and pharmaceutical R&D. As a result, he has handled and overseen numerous internal fraud and FCPA investigations both domestically and internationally involving a variety of third parties including distributors, wholesalers, clinical trial sites, and individual physician practices. He also has conducted numerous compliance program and overall risk assessments.
Dr. Whitelaw is a member of the planning committee for the 18th Annual Pharmaceutical and Medical Device Compliance Congress being held November 6-8, 2017 in Washington, D.C.
Dr. Whitelaw teaches life science compliance topics through the Health Law Institute at Mitchell Hamline School of Law.